Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W T Chu

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Blood|December 25, 2010
Polymorphisms in the multidrug resistance gene MDR1 (ABCB1) predict for molecular resistance in patients with newly diagnosed chronic myeloid leukemia receiving high-dose imatinibWendy Deenik, Bronno van der Holt, Jeroen J W M Janssen, et al.
Genetic Testing and Molecular Biomarkers|April 26, 2013
Addition of β-mercaptoethanol is a prerequisite for high-quality RNA isolation using QIAsymphony technology as demonstrated by detection of molecular aberrations in hematologic malignanciesSonja C P A M van der Poel-van de Luytgaarde, Wendy M C Geertsma-Kleinekoort, Chantal S Goudswaard, et al.
Haematologica|January 21, 2014
Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrationsSaman Abbas, Mathijs A Sanders, Annelieke Zeilemaker, et al.
Annals of Hematology|April 11, 2013
High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study groupNoortje Thielen, Bronno van der Holt, Gregor E G Verhoef, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Blood|December 25, 2010
Polymorphisms in the multidrug resistance gene MDR1 (ABCB1) predict for molecular resistance in patients with newly diagnosed chronic myeloid leukemia receiving high-dose imatinibWendy Deenik, Bronno van der Holt, Jeroen J W M Janssen, et al.
Genetic Testing and Molecular Biomarkers|April 26, 2013
Addition of β-mercaptoethanol is a prerequisite for high-quality RNA isolation using QIAsymphony technology as demonstrated by detection of molecular aberrations in hematologic malignanciesSonja C P A M van der Poel-van de Luytgaarde, Wendy M C Geertsma-Kleinekoort, Chantal S Goudswaard, et al.
Haematologica|January 21, 2014
Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrationsSaman Abbas, Mathijs A Sanders, Annelieke Zeilemaker, et al.
Annals of Hematology|April 11, 2013
High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study groupNoortje Thielen, Bronno van der Holt, Gregor E G Verhoef, et al.
Pageof 2